Hoa Le

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Radiation Therapy

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy 41 (8) (2024)
Jyoti D Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Maribel Salas, Chuntao Wu, David Sternberg, Stephen Esker, Jeffrey P Anderson, Aaron Crowley, Summera Q Zhou, Camryn Lieb, Haiyan Sun, Quan V Doan, Anu Santhanagopal, Karen L Reckamp
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy. Advances in therapy (2024)